Blood glutathione as independent marker of lipid peroxidation in heart failure

International Journal of Cardiology

Volumn 117, Issue 1, 2007, Pages 45-50

  Campolo, Jonica ^a   De Maria, Renata ^a   Caruso, Raffaele ^a   Accinni, Roberto ^a   Turazza, Fabio ^b   Parolini, Marina ^a   Roubina, Elèna ^a   De Chiara, Benedetta ^a   Cighetti, Giuliana ^c   Frigerio, Maria ^b   Vitali, Ettore ^b   Parodi, Oberdan ^a  

^a FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^b OSPEDALE NIGUARDA CA GRANDA   (Italy)

^c UNIVERSITY OF MILAN   (Italy)

Author keywords

Aminothiols; Chronic heart failure; Lipid peroxidation; Oxidative stress

Indexed keywords

ACETYLSALICYLIC ACID; ALPHA TOCOPHEROL; ASCORBIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BIOLOGICAL MARKER; CYSTEINE; CYSTEINYLGLYCINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLUTATHIONE; HOMOCYSTEINE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LIPID; MALONALDEHYDE;

ADULT; AMINO ACID BLOOD LEVEL; ARTICLE; BLOOD ANALYSIS; CARDIOVASCULAR DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY RISK; DISEASE MARKER; FEMALE; HEART FAILURE; HUMAN; LIPID PEROXIDATION; LOGISTIC REGRESSION ANALYSIS; MALE; MEDICAL ASSESSMENT; MULTIVARIATE ANALYSIS; OXIDATIVE STRESS; PREDICTION; PRIORITY JOURNAL; RISK FACTOR;

ADULT; ALPHA-TOCOPHEROL; ASCORBIC ACID; BIOLOGICAL MARKERS; FEMALE; GLUTATHIONE; HEART FAILURE, CONGESTIVE; HUMANS; LIPID PEROXIDATION; LOGISTIC MODELS; MALE; MALONDIALDEHYDE; MIDDLE AGED; MULTIVARIATE ANALYSIS; RISK FACTORS;

EID: 33947097325     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2006.04.065     Document Type: Article

References (34)

1. Halliwell B. The role of oxygen radicals in human disease, with particular reference to the vascular system. Homeostasis 23 (1993) 118-126
2. Prasad K., Gupta J.B., Kalra J., Lee P., Mantha S.V., and Bharadwaj B. Oxidative stress as a mechanism of cardiac failure in chronic volume overload in canine model. J Mol Cell Cardiol 28 (1996) 375-385
3. Mc Murray J., Chopra M., Abdullah I., Smith W.E., and Dargie H.J. Evidence of oxidative stress in chronic heart failure in humans. Eur Heart J 14 (1993) 1493-1498
4. Mak S., and Newton E.G. The oxidative stress hypothesis of congestive heart failure. Chest 120 (2001) 2035-2046
5. Oyama J., Shimokawa H., Momii H., et al. Role of nitric oxide and peroxynitrite in the citokine-induced sustained myocardial dysfunction in dogs in vivo. J Clin Invest 101 (1998) 2207-2214
6. Landmesser U., Spiekermann S., Dikalov S., et al. Vascular oxidative stress and endothelial dysfunction in patients with chronic heart failure. Role of xanthine oxidase and extracellular superoxide dismutase. Circulation 106 (2002) 3073-3078
7. Singal P.K., Khaper N., Palace V., and Kumar D. The role of oxidative stress in the genesis of heart disease. Cardiovasc Res 40 (1998) 426-432
8. Lopez Farre A., and Casado S. Heart failure, redox alterations and endothelial dysfunction. Hypertension 38 (2001) 1400-1405
9. Deneke S.M. Thiol-based antioxidants. Curr Top Cell Regul 36 (2000) 151-180
10. Lapenna D., De Gioia S., Cofani G., et al. Glutathione-related antioxidant defenses in human atherosclerotic plaques. Circulation 97 (1998) 1930-1934
11. Belch J.J., Bridges A.B., Scott N., and Chopra M. Oxygen free radicals and congestive heart failure. Br Heart J 65 (1991) 245-248
12. Chobanian A.V., Bakris G.L., Black H.R., et al. The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure. JAMA 289 (2003) 2560-2575
13. Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 285 (2001) 2486-2497
14. The Expert Committee on the diagnosis and classification of diabetes mellitus. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 25 (2002) S5-S20
15. Malinow M.R., Andrew G.B., and Krauss R.M. Homocysteine, diet and cardiovascular diseases. Circulation 99 (1999) 178-182
16. Accinni R., and Parodi O. Determination of plasma homocysteine. In: Drew A.F. (Ed). Atherosclerosis: experimental methods and protocols (2001), Humana Press 77-103
17. Accinni R., Campolo J., Bartesaghi S., et al. High-performance liquid chromatographic determination of total plasma homocysteine with or without internal standards. J Chromatogr A 828 (1998) 397-400
18. Hultqvist M., Hegbrant J., Nilsson-Thorell C., et al. Plasma concentrations of vitamin C, vitamin E and/or malondialdehyde as markers of oxygen free radical production during hemodialysis. Clin Nephrol 47 (1997) 37-46
19. Teissier E., Walters-Laporte E., Duhem C., Luc G., Fruchart J.C., and Duriez P. Rapid quantification of α-tocopherol in plasma ans low- and high-density lipoproteins. Clin Chem 42 (1996) 430-435
20. Cighetti G., Debiasi S., Paroni R., and Allevi P. Free and total malondialdehyde assessment in biological matrices by gas chromatography-mass spectrometry: what is needed for an accurate detection. Anal Biochem 266 (1999) 222-229
21. Castro P.F., Greig D., Perez O., et al. Relation between oxidative stress, catecholamines, and impaired chronotropic response to exercise in patients with chronic heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol 92 (2003) 215-218
22. Keith M., Geranmayegan A., Sole M.J., et al. Increased oxidative stress in patients with congestive heart failure. J Am Coll Cardiol 31 (1998) 1352-1356
23. McMurray J., McLay J., Chopra M., Bridges A., and Belch J.J. Evidence for enhanced free radical activity in chronic heart failure secondary to coronary artery disease. Am J Cardiol 65 (1990) 1261-1262
24. Diaz-Velez C.R., Garcia-Castineiras S., Mendoza-Ramos E., and Hernandez-Lopez E. Increased malondialdehyde in peripheral blood of patients with congestive heart failure. Am Heart J 131 (1996) 146-152
25. Falk E., Zhou J., and Moller J. Homocysteine and atherothrombosis. Lipids 36 (2001) S3-S11
26. Chin B.S., Langford N.J., Nuttal S.L., Gibbs C.R., Blann A.D., and Lip G.Y. Anti-oxidative properties of beta-blockers and angiotensin converting enzyme inhibitors in congestive heart failure. Eur J Heart Fail 5 (2003) 171-174
27. Ghatak A., Brar M.J., Agarwal A., et al. Oxy free radical system in heart failure and therapeutic role of oral vitamin E. Int J Cardiol 57 (1996) 119-227
28. Keith M.E., Jeejeebhoy K.N., Langer A., et al. A controlled clinical trial of vitamin E supplementation in patients with congestive heart failure. Am J Clin Nutr 73 (2001) 219-224
29. Blankenberg S., Rupprecht H.J., Bickel C., et al. Glutathione peroxidase 1 activity and cardiovascular events in patients with coronary artery disease. N Engl J Med 349 (2003) 1605-1613
30. Zachara B.A., Koterska D., Manitius J., et al. Selenium supplementation on plasma glutathione peroxidase activity in patients with end-stage chronic renal failure. Biol Trace Elem Res 97 (2004) 15-30
31. Shiomi T., Tsutsui H., Matsusaka H., et al. Overexpression of glutathione peroxidase prevents left ventricular remodeling and failure after myocardial infarction in mice. Circulation 109 (2004) 544-549
32. de Lorgeril M., Salen P., Accominotti M., et al. Dietary and blood antioxidants in patients with chronic heart failure. Insights into the potential importance of selenium in heart failure. Eur J Heart Fail 3 (2001) 661-669
33. Witte K.K., Clark A.L., and Cleland J.G. Chronic heart failure and micronutrients. J Am Coll Cardiol 37 (2001) 1765-1774
34. Bourdel-Marchasson I., and Emeriau J.P. Nutritional strategy in the management of heart failure in adults. Am J Cardiovasc Drugs 1 (2001) 363-373